SKAP1 Expression in Cancer Cells Enhances Colon Tumor Growth and Impairs Cytotoxic Immunity by Promoting Neutrophil

Jian Gao1, Jun Liu2, Jilin Lu2

  • 1State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China.

Insights

Src kinase associated phosphoprotein 1 (SKAP1) promotes colon cancer growth by enhancing neutrophil extracellular traps (NETs). Targeting SKAP1 or its downstream pathway may offer new therapeutic strategies for colon cancer.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Colon cancer mechanisms remain incompletely understood.
  • Src kinase associated phosphoprotein 1 (SKAP1) is identified as a novel gene linked to colon cancer.
  • Elevated SKAP1 expression correlates with poor patient survival.

Purpose of the Study:

  • To investigate the role of SKAP1 in colon cancer development and progression.
  • To elucidate the mechanisms underlying SKAP1-mediated tumor promotion.
  • To explore SKAP1 as a potential therapeutic target.

Main Methods:

  • Analysis of SKAP1 expression in colon cancer cells and patient data.
  • In vivo and in vitro studies to assess SKAP1's tumor-promoting effects.
  • Investigation of immune cell infiltration, neutrophil extracellular trap (NET) formation, and related signaling pathways (NFATc1, CXCL8).
  • Evaluation of therapeutic interventions targeting SKAP1, NETs, and adoptive natural killer cell therapy.

Main Results:

  • SKAP1 expression is significantly upregulated in colon cancer and predicts poor survival.
  • SKAP1 promotes colon tumor growth in vivo, involving neutrophils and enhanced NET formation.
  • SKAP1 upregulates CXCL8 via NFATc1, driving neutrophil infiltration and NETs.
  • Blocking CXCL8 or NFATc1 mitigates SKAP1-induced tumor promotion.
  • Inhibition of SKAP1-induced NETs enhances adoptive natural killer cell therapy efficacy.

Conclusions:

  • SKAP1 promotes colon cancer growth through a novel axis involving cancer cell/neutrophil NFATc1/CXCL8/NETs.
  • SKAP1 represents a potential therapeutic target for colon cancer treatment.
  • Targeting the SKAP1-NET axis could improve immunotherapy outcomes.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
859
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.6K